What We Do

Our Mission

Zielbio identifies novel high value disease targets and develops therapeutic interventions to improve patient outcomes  

Proprietary Platform

Zielfind™ combines the power of functional, high throughput screening with large content data analytics to identify high value targets 

Promising Oncology Pipeline

Pipeline of proprietary targets, including lead compound ZB131, a CSP-targeting functional antibody with potentially unprecedented immune activation and tumor cell killing